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Abstract Phospholipase A2 (PLA2)-mediated hydrolysis of 
membrane phospholipids was measured by ellipsometry, and 
the inhibition of this process by annexin V was studied. Planar 
membranes, consisting of phosphatidylcholine, phosphatidyletha-
nolamine, and phosphatidylserine (PC/PE/PS; 54:33:13, on 
molar basis), were degraded by pancreatic PLA2 , and the rate of 
hydrolysis was limited to about 0.7%/min. The influence of 
graded coverage of the membrane with annexin V was studied. 
The degree of PLA2 inhibition was nonlinearly related to the 
amount of membrane-bound annexin V, and binding of only 12% 
and 54% of full membrane coverage resulted in, respectively, 
50% and 93% inhibition. These findings indicate that the 
inhibition of PLA2-mediated hydrolysis by annexin V cannot 
be simply explained by shielding of phospholipid substrates from 
the enzyme. Moreover, the present results leave room for a role 
of endogenous annexin V in regulating phospholipid turnover in 
the plasma membrane of parenchymal cells such as cardiomyo-
cytes. 
1. Introduction 
Under normal conditions the membrane phospholipids of 
cardiomyocytes are subjected to a continuously balanced deg-
radation and resynthesis cycle. However, under pathophysio-
logical circumstances, like ischemia/reperfusion, there is a net 
degradation of phospholipids [1-3]. The mechanisms under-
lying the net decline of the membrane phospholipid pool 
under pathophysiological circumstances are incompletely 
understood. It is suggested that the phospholipid degradation 
rate, although enhanced, is controlled by intrinsic factors dur-
ing ischemia/reperfusion [3]. One of these factors might be the 
binding to the membrane of annexin V, a member of a family 
of calcium and phospholipid binding proteins (for reviews of 
the annexins see [4,5]). Annexin V was found to be present at 
the sarcolemma of the cardiac myocyte [6]. The protein binds 
to membranes containing negatively charged phospholipids 
[7,8], such as phosphatidylserine (PS), which under normal 
conditions are predominantly located in the inner leaflet of 
the cardiac cellular membrane [9]. 
Antiphospholipase activity in vitro of the annexins was first 
reported for annexin I and later also for other annexins [4]. 
The inhibitory mechanism proposed involves masking of sub-
strate (phospholipids) by annexins [10]. As such, annexins are 
thought to be Ca 2 + -dependent non-specific inhibitors of phos-
pholipases. This notion suggests that they may be involved in 
the phospholipid homeostasis in the heart. However, the esti-
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mated molar ratio of annexin V over the phospholipids of the 
inner leaflet, which is in the order of 1:1250, does not support 
a role for annexin V in the cardiac myocyte by simply shield-
ing off phospholipids [6]. 
The aim of the present study was to investigate the potency 
of annexin V to inhibit phospholipase A2 (PLA2)-mediated 
hydrolysis of phospholipids at low PLA 2 activity, i.e., yielding 
about 1% of phospholipid hydrolysis per minute, which is in 
the same range as maximally observed in cardiac tissue [11]. A 
new ellipsometric technique for simultaneous in situ monitor-
ing of the binding of annexin V to planar phospholipid mem-
branes, as well as the rate of membrane degradation by PLA 2 
was used [12]. This technique allows accurate control of the 
degree of coverage of the phospholipid surface with annexin V 
and continuous measurement of the membrane degradation 
rate. 
2. Materials and methods 
2.1. Materials 
Dioleoyl-phosphatidylcholine (PC) and dioleoyl-phosphatidylserine 
(PS) were obtained from Avanti Polar Lipids (Alabaster, AL). Dio-
leoyl-phosphatidylethanolamine (PE) and porcine pancreatic phos-
pholipase A2 were purchased from Sigma (St. Louis, MO). Recombi-
nant annexin V was prepared as described [13]. Silicon wafers (1-0-0, 
type n, phosphorus doped; thickness: 500 um) were obtained from 
Aurel GmbH (Landsberg, Germany). All chemicals used were of the 
highest grade available. 
2.2. Planar bilayers 
Planar bilayers on silicon discs were prepared by adsorption of 
small unilamellar vesicles as described [14]. Briefly, vesicles were pre-
pared by mixing PC, PE and PS in a molar ratio of 54:33:13, drying 
of the lipids under a stream of nitrogen, and sonication of the lipid 
dispersions (1 mM phospholipids) in HEPES buffer (50 mM, pH 7.4, 
100 mM NaCl) for 10 min on ice at 7.5 urn peak-to-peak amplitude. 
Vesicles were added at a final concentration of 20 uM phospholipid to 
a vessel containing a rotating hydrophilic silicon disc. Adsorption of 
vesicles to the disc results in the formation of a continuous planar 
bilayer [15]. After formation of a continuous planar membrane sur-
face on the disc (2 cm2), non-bound vesicles were removed. The mem-
brane-coated disc was transferred, avoiding exposure to air, to the 
ellipsometer cuvette filled with 5 ml of HEPES buffer containing 
1 mM CaCl2. In all experiments the discs were rotated at a constant 
angular velocity of 78 rad/s. Phospholipid concentrations were deter-
mined by phosphate analysis [16]. 
2.3. Ellipsometry 
Changes in the adsorbed surface mass were measured directly on 
the rotating disc by ellipsometry at 21°C [17,18]. Light from a He-Ne 
laser passes a polarising prism and is reflected by the rotating silicon 
disc, mounted in the ellipsometer cuvette. After reflection the laser 
beam passes a second prism, the analyzer, before reaching a photo-
diode. Adsorption of biomolecules to the silicon disc results in 
changes of the polarization state of the reflected light. The positions 
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of the polarizer and analyzer are automatically adjusted by a com-
puter program such that the light intensity reaching the photodiode is 
minimized (null-ellipsometry). From the polarizer and analyzer posi-
tions the amount of adsorbed phospholipid mass can be calculated 
with a precision of 3-5 ng/cm2, that is, about 1% of the mass of an 
adsorbed planar bilayer (445 ng/cm2, see Section 3). 
2.4. PLAi-dependent phospholipid hydrolysis 
After preparation of a planar bilayer on a silicon disc and measure-
ment of a baseline level of surface mass, hydrolysis of membrane 
phospholipids was started by addition of PLA2 (0.3-30 ng/ml). Sub-
sequently, the cuvette was continuously flushed at 5 ml/min with the 
same concentrations of PLA2. This procedure was performed in order 
to minimize depletion of PLA2 from the bulk phase, for instance due 
to adsorption of PLA2 to the cuvette walls. Also, the hydrolysis prod-
ucts appearing in the buffer were thus removed. 
2.5. Measurement of annexin V binding and phospholipid hydrolysis 
Annexin V binding was started by addition of annexin V at final 
concentrations ranging from 0.1 to 1 Ug/ml. Adsorption was inter-
rupted by removal of annexin V from the bulk phase by flushing 
the cuvette with 50 ml of buffer containing 1 mM CaC^. This pro-
cedure takes advantage of irreversible binding of annexin V to planar 
membranes, probably caused by formation of annexin V clusters on 
the surface [19]. It results in partial coverage of the membrane with 
annexin V. Throughout this report, partial coverage will be expressed 
as percentage of the maximal annexin V binding capacity. When a 
stable level of adsorbed annexin V surface mass was recorded, phos-
pholipid hydrolysis was started by addition of PLA2 (1 ng/ml), and 
the cuvette was continuously flushed with PLA2 (1 ng/ml) at 5 ml/min. 
After 2000 s, EDTA (2 mM final concentration) was added to remove 
annexin V from the membrane and to inhibit PLA2 activity. 
3. Results 
3.1. Phospholipid hydrolysis of planar bilayers by PLA2 
Exposure of rotating hydrophilic silicon discs to phospho-
lipid vesicles composed of PC/PE/PS (54:33:13, mol/mol/mol) 
resulted in adsorption of vesicles and formation of a stable 
membrane, as shown by the initial part of the curves in Fig. 1, 
i.e., prior to addition of PLA2. The adsorbed lipid mass was 
445 ± 15 ng/cm2 (mean±SD) in the various experiments. For 
clarity, the initial surface mass was normalized to 100% for 
each experiment. After recording the baseline level of lipid 
mass, phospholipid hydrolysis was started by addition of por-
cine pancreatic PLA2 (varying from 0.3 to 30 ng/ml). The 
observed desorption rates, reflecting phospholipid hydrolysis 
and release of hydrolytic products from the membrane, in-
creased with the PLA2 concentration used. Desorption rates 
ranged from about 0.5%/min with 0.3 ng/ml PLA2 to about 
4%/min with 30 ng/ml PLA2. Product desorption rates were 
not linear with the PLA2 concentration, as indicated by a plot 
of the initial rates against PLA2 concentration (Fig. 1, insert). 
In order to keep the rate of phospholipid hydrolysis within the 
(patho)-physiological range of maximally 1 %/min (see Section 
4), a fixed concentration of 1 ng/ml PLA2 was used. 
3.2. Phospholipid hydrolysis of membranes partially covered 
with annexin V 
PC/PE/PS membranes were partially covered with annex-
in V by addition of annexin V (0.1-1 ug/ml) to the cuvette, 
monitoring of annexin V binding, and flushing of the cuvette 
with buffer when the desired amount of protein had adsorbed. 
Maximal annexin V coverage observed in the presence of 
1 mM Ca2+ was about 190 ng/cm2, which is in agreement 
with previous results [8]. As shown in Fig. 2, membranes 
were prepared with 0, 5, 12, 27, 54 and 100% of maximal 
annexin V adsorption. Hydrolysis of membrane phospholipids 
was started by addition of PLA2 (1 ng/ml). At the end of the 
experiments EDTA was added, resulting in instantaneous de-
sorption of annexin V and complete inhibition of PLA2 activ-
ity. In Fig. 2, the amount of immediately desorbing annex-
in V, after addition of EDTA, was about equal to the amount 
of initially adsorbed annexin V, because either the degraded 
fraction of the membrane or the amount of adsorbed annex-
in V was small. The resulting partial annexin V adsorptions to 
the membrane (with the number of experiments) were: 
0 (w=10), 9 (w = 4), 23 (« = 3), 50 (w = 3), 100 (w = 2) and 
190 (« = 1) ng/cm2. Standard errors of the mean are presented 
for the four lower coverages with annexin V. It is apparent 
from Fig. 2 that increased surface coverage with annexin V 
resulted in decreased phospholipid hydrolysis rates. 
Fig. 3 more directly illustrates the relation between ob-
served mean phospholipid hydrolysis rates and annexin V sur-
face coverage. Hydrolysis rates were calculated from the ad-
sorbed phospholipid surface mass, measured before addition 
of annexin V, minus the amount after 2000 s of PLA2 action, 
PLA2 cone. 
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Fig. 1. Phospholipid hydrolysis of PC/PE/PS (54:33:13, mo/mol/mol) membranes by PLA2. PLA2 was added (arrow) at concentrations as indi-
cated in the figure. 
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as inferred from the remaining phospholipid mass after annex-
in V desorption and PLA2 inhibition by addition of EDTA. 
Already at low surface coverages significant inhibition of the 
phospholipid hydrolysis rate was observed. For instance, 
about 22% inhibition of PLA2 activity occurred when the 
membrane was covered for only 5% with annexin V, 50% 
inhibition for only 12% coverage and almost complete inhibi-
tion for only 50% coverage. 
4. Discussion 
In the present study we examined the effect of annexin V on 
PLA2-dependent degradation of planar model membranes. 
Ellipsometry was used to measure membrane coverage with 
annexin V and PLA2 -dependent phospholipid hydrolysis at 
the same time. Previously, we have shown that the degrada-
tion curves reflect desorption of degradation products, while 
unaffected phospholipids remain adsorbed [12]. Adsorption of 
PLA2 to the membrane cannot be observed, because for the 
low PLA2 concentration of 1 ng/ml, even when the PLA2 
adsorption rate would be transport-limited, the PLA2 adsorp-
tion rate would still be less than a few percent of product 
desorption rates [12]. Thus, even with the highest PLA2 con-
centration used, desorption rates adequately reflect true de-
sorption of phospholipid hydrolysis products. 
4.1. Choice of planar model membranes 
Planar membrane surfaces were used and these are more 
comparable with the sarcolemma than vesicles. For instance, 
they allow formation of irreversibly binding annexin clusters, 
and thereby could decrease the lateral mobility of membrane-
bound PLA2, while such clustering is hampered by high sur-
face curvature in phospholipid vesicles [19]. 
Fig. 2. Effect of annexin V surface coverage on PLA2-dependent 
phospholipid hydrolysis. Membranes were partially covered with an-
nexin V. The degree of coverage is indicated in the figure. Phospho-
lipid hydrolysis was started after 500 s by addition of PLA2 (1 ng/ 
ml). After 2500 s, EDTA was added to remove annexin V from the 
membrane and to inhibit PLA2 activity. Solid curves present aver-
ages and dashed lines indicate the standard errors of the mean. 
Fig. 3. Phospholipid hydrolysis rates as function of annexin V sur-
face coverage. The mean phospholipid hydrolysis rate of all individ-
ual experiments, summarized in Fig. 2, are plotted. Degradation 
rates are expressed as percentage of the original amount of phos-
pholipid adsorbed on the rotating disc. 
4.2. Choice of the phospholipid composition of the membrane 
Whereas the outer leaflet of the sarcolemma mainly consists 
of PC and sphingomyelin, the inner leaflet mainly contains 
PC, PE, PS and a small fraction of phosphatidylinositol 
(PI). The composition used in the present study, of PC/PE/ 
PS at molar ratios of 54:33:13, roughly resembles the compo-
sition of the sarcolemmal inner leaflet [9]. It should be noted, 
however, that the artificial membrane did not contain natu-
rally occurring membrane proteins as does the sarcolemma, 
and thus on this point is far from physiological. Possible 
consequences of this are discussed below. 
4.3. Choice for pancreatic PLA2 as model enzyme 
Three different phospholipases A2 have been detected in 
cardiac tissue: group II PLA2, high molecular weight PLA2, 
and plasmalogen-specific PLA2 [20]. In ischemia-induced 
membrane damage of the heart, group II PLA2 is suggested 
to be of major importance [21]. Additional evidence for this 
role has been provided by experiments showing that other 
fatty acids than arachidonic acid are also found as hydrolytic 
products [11]. Because high molecular weight PLA2 is very 
specific for sn-2-arachidonyl-containing phospholipids, it 
thus seems less important for ischemia-induced phospholipid 
hydrolysis. In addition, mainly lysophospholipids are found as 
phospholipid degradation products [11], and this rules out the 
plasmalogen-specific PLA2 as a likely candidate. Since puri-
fied heart-specific group II PLA2 was not available in suffi-
cient quantity, pancreatic PLA2 was used in the present study 
because of its structural and functional resemblance to group 
II PLA2 [22]. The Ca
2+-requirement of pancreatic PLA2 (and 
of heart-specific group II PLA2) for optimal activity largely 
exceeds normal intracellular levels [22]. However, ischemic 
conditions may result in elevated intracellular Ca2+ concen-
trations [23]. Furthermore, it has been proposed that in close 
vicinity to the sarcolemma Ca2+ concentrations are higher 
than in the cytoplasm, and could be in range of the Ca2+ 
concentration used in the present study (1 mM) [24,25]. 
4.4. Choice of the PLA2 concentration 
The average phospholipid hydrolysis rate of 0.7%/min, ob-
served for a PLA2 concentration of 1 ng/ml, is in the range of 
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degradation rates observed in (patho)physiological systems. 
For instance, it was shown that endogeneous hydrolytic activ-
ity in rat cardiac tissue, deliberately damaged by freezing and 
thawing prior to storage under anoxic conditions, is about 1% 
phospholipid breakdown per minute [11]. This may indicate 
the maximal phospholipase activity at membranes of the car-
diac myocyte. 
4.5. Possible mechanisms for PLA2 inhibition by annexin V 
The mechanism of phospholipase inhibition by annexins is 
still controversial. Specific protein-protein interactions be-
tween annexins and PLA2 have been proposed, but evidence 
for such interactions is not conclusive [4]. It was observed that 
by increasing the phospholipid to annexin ratio, inhibition of 
PLA2 was abolished [10,26]. This led to the so-called substrate 
depletion model, with annexin V masking the substrate phos-
pholipids [10]. It should be noted that in most experiments the 
actual coverage of the phospholipid substrates with annexins 
was not precisely known. Our results indicate that simple 
masking of the membrane phospholipids is not sufficient to 
describe the observed inhibition. Furthermore, for higher (20-
30 ng/ml) PLA2 concentrations, substantial phospholipid hy-
drolysis was observed even when the membranes were maxi-
mally covered with annexin V (results not shown). Obviously, 
these membranes still provide binding sites for PLA2, in 
agreement with the observation that coagulation factors Xa, 
Va and prothrombin may still bind to such maximally covered 
membranes [19]. 
Annexin V binds to PS with higher affinity then to PC and 
PE [8,27], and this could cause clustering of PS. Indeed, ex-
perimental evidence for annexin-induced clustering of anionic 
phospholipids such as phosphatidic acid [28] and phosphati-
dylglycerol [28,29] has been provided. The binding affinity of 
pancreatic PLA2 for PC membranes is low and is markedly 
enhanced by the incorporation of anionic phospholipids, like 
PS [30]. Therefore, clustering of PS by annexin V could ex-
plain more than proportional inhibition of PLA2. 
Annexin V could also interfere with the influence of phos-
pholipid hydrolysis products on PLA2 activity. Although the 
precise role of hydrolysis products in PLA2 action is not com-
pletely elucidated [31], their accumulation in the membrane 
may greatly reduce the activity of PLA2 by product inhibition 
or substrate dilution [32-34]. Although in our experimental 
set-up the hydrolysis products desorb from the membrane, 
some accumulation is inevitable. From a product desorption 
rate of 0.7%/min, as observed with 1 ng/ml PLA2, a product 
mole fraction in the membrane of about 0.03 can be calcu-
lated [12]. A similar value can be estimated from the remain-
ing desorption after inhibition of PLA2 by EDTA (Fig. 2, 
lower curve). Although modest, the non-linear dependence 
of the rate of hydrolysis on PLA2 concentration (Fig. 1, inset) 
suggests strong product inhibition, and annexin V could in-
crease this effect by interfering with the desorption of degra-
dation products from the membrane. However, no effect of 
annexin V binding was observed on the product desorption 
rates from PS/PE/PC membranes containing 10 mole % of 
lysoPC and oleic acid (result not shown). 
It has been reported that the annexins reduce the lateral 
mobility of phospholipids [26,35,36], even of lipid components 
with low affinity for annexins such as PC [35,36]. In the latter 
studies it was concluded that fluid-fluid phase separation oc-
curred upon annexin binding to PG/PC membranes. Reduced 
lateral mobility of PC may thus be the result of a decrease in 
free space in which the lipid can diffuse. Similarly, annexin V 
may decrease the rate of lateral diffusion of phospholipid 
hydrolysis products away from their production site, thereby 
promoting local product inhibition. This effect could be en-
hanced by simultaneous reduction of the lateral mobility of 
PLA2 molecules by annexin V clusters. 
4.6. Is annexin V a candidate for regulating cellular PLA2 
in vivo? 
The adsorbed mass of phospholipids on silicon discs is 445 
ng/cm2, that is about 0.55 nmol phospholipids per cm2. We 
observed 50% inhibition of PLA2 activity at a coverage of the 
phospholipid membrane with 23 ng/cm2 of annexin V (12% of 
the maximal annexin V coverage), that is 0.65 pmol/cm2. 
Hence, the molar annexin V/phospholipid ratio is 1:850 for 
a bilayer and 1:425 for a monolayer. This ratio is about 3 
times the estimated annexin V over sarcolemmal phospholipid 
ratio of 1:1250 in the rat cardiac myocyte [6]. However, a 
major part of the sarcolemma consists of proteins which, by 
bulging from the membrane, could make parts of the mem-
brane inaccessible for membrane-directed enzymes. Also, cy-
toskeletal proteins are partially covering the inner phospho-
lipid bilayer. Thus, the ratio of annexin V over freely 
accessible phospholipid may be considerably higher than 
1:1250. Together with our finding that low phospholipid cov-
erages by annexin V are sufficient for substantial PLA2 inhib-
ition, this suggests that annexin V could be of biological im-
portance in the regulation of phospholipid degradation at the 
sarcolemma of the cardiac myocyte. 
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